Millennium Management »

Chemomab Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $10k 20k 0.51

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Amazon Put Option (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
salesforce Put Option (CRM)

View all positions for Millennium Management

Top funds holding Chemomab Therapeutics

OrbiMed Advisors
Ikarian Capital
Two Sigma Investments
Two Sigma Advisers
Citadel Advisors
Kestra Private Wealth Services
Virtu Financial
Millennium Management
Rhumbline Advisers
Advisor Group Holdings
Moser Wealth Advisors

View all funds holding Chemomab Therapeutics